Preoperative chemotherapy in non-small-cell lung cancer: Nothing new in N2 disease [2]

Journal of Clinical Oncology

Volumn 20, Issue 10, 2002, Pages 2603-2604

  De Pas, Tommaso ^a   Pastorino, Ugo ^a   Spaggiari, Lorenzo ^a   Curigliano, Giuseppe ^a   De Braud, Filippo ^a   Robertson, Chris ^a  

^a Scottish Centre for Infection and Environmental Health   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER STAGING; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT FAILURE;

EID: 0037093090     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.20.10.2603     Document Type: Letter

References (4)

1. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer
2. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
3. Randomized trial of neoadjuvant therapy for lung cancer: Interim analysis
4. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer